Michael Howell - 18 May 2024 Form 4 Insider Report for Zura Bio Ltd (ZURA)

Role
Chief Scientific Officer and Head of Translational Science
Signature
/s/ Michael Howell
Issuer symbol
ZURA
Transactions as of
18 May 2024
Net transactions value
-$59,653
Form type
4
Filing time
08 Aug 2024, 16:15:07 UTC
Previous filing
06 Sep 2024
Next filing
21 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZURA Class A ordinary shares Tax liability $59,653 -9,860 -8.6% $6.05 104,535 18 May 2024 Direct F1
holding ZURA Class A ordinary shares 7,987 18 May 2024 By Corporation F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.
F2 These shares are beneficially owned by Mountaineer Biosciences, Inc. ("Mountaineer"). The Reporting Person is the Co-Founder of Mountaineer and, as such, has the power to vote and dispose of the ordinary shares held by Mountaineer. The Reporting Person disclaims beneficial ownership in these securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Remarks:

Chief Scientific Officer and Head of Translational Science